Clinical trial · Interventional
Web-based Tailored Information and Support for Patients With a Neuroendocrine Tumor
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Patients with a neuroendocrine tumor (NET) frequently suffer from physical as well as psychosocial complaints. Patients may experience various symptoms from tumor burden and secreted hormones by the tumor. They also can have complaints due to their anti-cancer treatment and accompanying side effects. Adequate information is an essential aspect of supportive care. Patients need for information and care remain frequently unnoticed. The aim of the current study is to test the effectiveness of a web-based tailored information and support system to support patients' information and care needs. Key features of this website are patient self-screening of physical and psychosocial problems, tailored patient education on reported problems and self-referral to professional health care. The investigators expect that the website is a highly suitable medium to provide tailored information and support.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Neuroendocrine Tumor | Neuroendocrine Tumor | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Standard care | Other | — | UNRESOLVED |
| Web-based tailored information and support system | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- OTHER
- label
- Standard care
- description
- The control group will receive standard care.
- interventionNames
- Other: Standard care
- type
- EXPERIMENTAL
- label
- Experimental group
- description
- In addition to standard care, the experimental group will be given access to the web-based tailored information and support system (with a username/password)
- interventionNames
- Other: Web-based tailored information and support system
Primary outcomes (1)
- measure
- A composite outcome of difference in distress and the mean improvement of the global score of the EORTC QLQ-INFO 25
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 90 Years
Show eligibility criteria text
Inclusion Criteria: * Adult NET patients (aged ≥ 18 years of age) with any tumor site and disease stage. * Ability to comprehend Dutch (both reading and writing). * Informed consent provided Exclusion Criteria: * Estimated life expectancy less than 3 months. * Patients who have a history of another primary malignancy, except for radical and adequately treated malignancies from which the patient has been disease free for ≥ 3 years * Patients who participated in the WIN-pilot study.
References
Publications (1)
- DERIVEDde Hosson LD, Bouma G, Stelwagen J, van Essen H, de Bock GH, de Groot DJA, de Vries EGE, Walenkamp AME. Web-based personalised information and support for patients with a neuroendocrine tumour: randomised controlled trial. Orphanet J Rare Dis. 2019 Feb 28;14(1):60. doi: 10.1186/s13023-019-1035-3. PMID 30819238